OCS依存性の重症性喘息の患者におけるメポリズマブの有効性:現実世界の研究
Sevim Bavbek1, Mona Al-Ahmad2,3, Hala Samaha4
1Department of Chest Diseases, Division of Immunology and Allergic Diseases, Ankara University School of Medicine, Ankara, Türkiye.
Advances in therapy
|August 29, 2025
まとめ
メポリズマブは,重度の喘息患者の経口用コルチコステロイド (OCS) の使用と悪化を,複数の国で有意に減少させた. この生物学的治療は,OCS依存症の患者の症状制御を改善しました.
科学分野:
- 肺科
- 免疫学
- 薬理学について
背景:
- 口服用コルチコステロイド (OCS) は,著しい副作用にもかかわらず,アジア,ラテンアメリカ,中東における重度の喘息の主要な治療法であった.
- Mepolizumabは,抗インタールイキン-5単体抗体であり,重度の喘息に対する標的生物学的治療法を提供します.
- 治療の有効性を理解するには 代表者が不足している地域からの実際のデータが不可欠です
研究 の 目的:
- 口服用コルチコステロイド (OCS) 依存症の重度の喘息患者におけるメポリズマブの有効性を評価する.
- メポリズマブのOCS使用,悪化,症状制御への影響を現実の環境で評価する.
- 重症性喘息の生物学的研究で,以前は限られた地域からのデータを分析する.
主な方法:
- メポリズマブを投与された重度の喘息の成人の多国間観察コホート研究 (NEST).
- 開始時にまたは26週間前に維持OCSとして定義されたOCS依存症.
- メポリズマブ投与開始前と後の12ヶ月のデータを収集し,OCS使用,臨床的に有意な悪化 (CSEs),および喘息症状のコントロールに焦点を当てた.
主要な成果:
- 患者の58. 4%がOCS依存症でした.
- メポリズマブ投与開始後,87. 6%が低用量OCSを受け,68. 9%がOCSを完全に停止した.
- 臨床的に有意な悪化は76. 9%減少し,患者の72. 5%が喘息症状の改善を示した.
結論:
- メポリズマブは,OCS依存症の重度の喘息患者のOCSの使用と投与量を効果的に減少させた.
- メポリズマブは喘息の悪化を大幅に減らし,症状のコントロールを改善しました.
- これらの発見は,メポリズマブの重度の喘息の管理における役割を支持する.
関連する概念動画
01:26COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
383
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
383
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K